HIV-1 Vaccines C1C62(University of North Carolina, Chapel Hill)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameHIV-1 Vaccines C1C62(University of North Carolina, Chapel Hill)

Drug Alias NameChAdOx1.tHIVconsv1+C62(University of North Carolina, Chapel Hill)C1C62

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of North Carolina At Chapel Hill

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina At Chapel Hill

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A